Stay updated with breaking news from David Mangone. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
In a pivotal moment for the American cannabis sector, the U.S. Department of Health and Human Services (HHS) has proposed a reclassification of cannabis to the DEA. This could shift cannabis from its current Schedule I status, bringing potential upheaval in the perception and market dynamics of the plant.
The U.S. Department of Health & Human Services (HHS) has recommended that marijuana be moved from Schedule I to Schedule III under federal law. This decision has widespread implications for the cannabis market's trajectory in 2024, touching on diverse areas ranging from policy and business to the very science underpinning such classifications. The change in classification is not just a regulatory adjustment. For stakeholders in the cannabis industry, this decision signifies an acknowledgment of
The U.S. Department of Health & Human Services (HHS) has recommended that marijuana be moved from Schedule I to Schedule III under federal law.
And DOJ asks appeals court to restore access to Trump Mar-a-Lago documents.
A Federal Reserve-issued digital dollar could speed up payments, expand financial access and reduce financial crime. But it also brings trade-offs that policymakers are only just beginning to consider.